Effect of thyroxine on immune response in C57Bl/6J mice.
The effect of T4 treatment (40 micrograms, 5 times/week) on immune function in C57Bl/6J mice was studied. The primary antibody synthesis as measured by the plaque-forming cell (PFC) assay demonstrated significant suppression in mice treated with T4 for 30 days. Mitogen assays using PHA and Con A demonstrated significant suppression of cellular immune responses as measured by [3H]thymidine incorporation. The effect was reversed when the treatment was discontinued and a normal response reappeared after 14 days. Allogeneic skin grafts (donor A/J mice) showed prolonged survival (median survival time, 13.5 days) in T4-treated mice as compared to control untreated mice (median survival time, 11 days). Further experiments using Chromium 51 assay for delayed type hypersensitivity also showed suppressed response. These results suggest that treatment with T4, in the above doses and duration, cause immunosuppression in C57Bl/6J mice.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D005260:Female; D006085:Graft Survival / Q000187:drug effects; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007075:Immunoglobulin M / Q000096:biosynthesis; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008805:Mice, Inbred A / Q000276:immunology; D008810:Mice, Inbred C57BL / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D013974:Thyroxine / Q000494:pharmacology*
D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D013974:Thyroxine